Details of the Drug Reposition

General Information of This Drug (ID: DM704AN)

Drug Name
Sapacitabine   DM704AN
Synonyms CYC682
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Acute myelogenous leukaemia DISCSPTN 2A41 Phase 3 [1]
Acute myeloid leukaemia DIS0BM1I 2A60 Phase 3 [2]
------------------------------------------------------------------------------------
4 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Myelodysplastic syndrome DISYHNUI 2A37 Phase 2 [1]
Pancreatic cancer DISJC981 2C10 Phase 2 [3]
Breast cancer DIS7DPX1 2C60-2C65 Phase 2 [3]
Ovarian cancer DISZJHAP 2C73 Phase 2 [3]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT01303796) A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia. U.S. National Institutes of Health.
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)